Hypertensive Emergency and Urgency

Hypertensive emergency is defined as severe elevation of blood pressure (typically ≥180/120 mmHg) accompanied by evidence of acute end-organ damage, requiring immediate pharmacological intervention to prevent irreversible morbidity and mortality. Hypertensive urgency represents severe BP elevation without acute end-organ damage, managed with oral antihypertensive agents over hours to days. These presentations account for approximately 1-2% of all hypertension office visits but represent up to 5% of emergency department presentations in urban centers, with higher incidence in African American populations, patients with underlying chronic hypertension, and those with medication non-compliance. Recognition and appropriate risk stratification between emergency and urgency is critical for clinical practice, as misclassification leads to either unnecessary aggressive treatment (risking stroke and myocardial infarction from overly rapid BP reduction) or inadequate management (risking target organ damage). This distinction fundamentally guides therapeutic intensity and timeline, making it essential for USMLE Step 2 CK preparation and safe clinical practice.

The transition from chronic hypertension to hypertensive emergency involves acute disruption of normal autoregulatory mechanisms and subsequent establishment of a pathologic cycle of vascular injury and BP elevation.

Normal cerebral autoregulation maintains constant cerebral blood flow across mean arterial pressures (MAP) of 50-150 mmHg through myogenic mechanisms and sympathetic denervation of resistance vessels. In hypertensive emergency, acute BP elevation exceeds the upper limit of autoregulation, causing forced vasodilation and increased cerebral capillary hydrostatic pressure. This leads to hypertensive encephalopathy through blood-brain barrier breakdown, endothelial swelling, and vasogenic edema. The renal afferent arteriole similarly loses autoregulatory capacity when systolic BP exceeds 180-200 mmHg, causing acute glomerular capillary injury, fibrinoid necrosis of arterioles, and acute kidney injury (AKI). The pathologic nature of this injury distinguishes emergency from urgency—in urgency, autoregulation remains partially intact despite high absolute BP.

Sustained severe hypertension causes direct mechanical stress on endothelial cells, disrupting the endothelial glycocalyx and triggering endothelial dysfunction. This activates the coagulation cascade, platelet aggregation, and fibrin deposition in small vessels, manifesting as microangiopathic hemolytic anemia with schistocytes on blood smear. The same mechanism causes acute arterial necrosis with fibrinoid necrosis—transmural vessel wall necrosis visible on kidney or skin biopsy as bright pink homogeneous material on H&E staining. Vascular smooth muscle cells undergo apoptosis and release intracellular contents, perpetuating inflammation and vessel damage.

The acute reduction in renal perfusion pressure triggers massive renin release from juxtaglomerular cells, overwhelming any negative feedback from elevated angiotensin II and aldosterone. This positive feedback loop accelerates vasoconstriction and salt retention, worsening hypertension. Simultaneously, baroreceptor dysfunction (from chronic hypertension resetting the baroreflex set point) and acute sympathetic activation from catecholamine excess (in cases of pheochromocytoma or cocaine use) amplify vasoconstriction. The combination of RAAS activation and sympathetic hyperactivity creates a self-perpetuating hypertensive crisis—higher BP triggers further neurohormonal activation, which further elevates BP.

Endothelial injury exposes tissue factor and von Willebrand factor, activating extrinsic coagulation. Platelet adhesion and aggregation occur, with activation of thrombin generation and fibrin formation. In severe cases, this manifests as thrombotic microangiopathy with mechanical hemolysis, thrombocytopenia, and AKI—the clinical triad of thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome (HUS). This is distinct from disseminated intravascular coagulation (DIC), which shows consumption of both clotting factors and platelets; in hypertensive emergency-associated microangiopathy, clotting studies may be normal or show mild prolongation with isolated thrombocytopenia.

The sudden increase in systemic vascular resistance dramatically increases left ventricular (LV) afterload. In patients with underlying LV hypertrophy from chronic hypertension, this acute afterload stress precipitates acute decompensated heart failure through several mechanisms: (1) increased myocardial oxygen demand exceeds coronary supply; (2) increased diastolic stiffness from hypertrophic remodeling prevents adequate filling; (3) mitral regurgitation develops from papillary muscle ischemia and geometric distortion. This is why flash pulmonary edema is a classic presentation of hypertensive emergency in patients with chronic hypertension and LV hypertrophy.

While hypertensive emergency increases perfusion pressure, it paradoxically causes ischemia in two ways: (1) demand ischemia—the marked increase in BP and heart rate increases myocardial oxygen consumption, exceeding supply in vessels with fixed stenosis; (2) supply ischemia—acute coronary vasospasm occurs with catecholamine excess (cocaine, amphetamines, pheochromocytoma). In the cerebral circulation, even brief periods of MAP >220 mmHg can cause forced vasodilation and vasogenic edema. Conversely, overly rapid BP reduction in patients with chronic hypertension (>25% in 1 hour) causes cerebral ischemic stroke because the autoregulatory curve shifts rightward in chronic hypertension—patients become dependent on higher BP for adequate cerebral perfusion.

Accounts for approximately 50-60% of hypertensive emergencies. Usually precipitated by acute medication non-compliance (>60% of cases), emotional stress, or dietary sodium excess in patients with long-standing hypertension. The chronic elevation of BP causes structural vascular changes (medial hypertrophy, endothelial dysfunction) that predispose to acute decompensation. African American patients have higher incidence of primary hypertensive emergency due to greater sodium sensitivity and different RAAS genetics.

Acute glomerulonephritis (post-infectious, lupus, ANCA-associated vasculitis) and acute kidney injury from any cause trigger hypertensive emergency through fluid retention and RAAS activation. Renovascular hypertension from acute renal artery dissection or thrombosis causes severe acute hypertension through massive renin release. Polycystic kidney disease with progressive renal dysfunction predisposes to hypertensive emergency. Importantly, in acute glomerulonephritis, the presence of active urinary sediment (dysmorphic RBCs, RBC casts) with hypertensive emergency is a red flag for rapidly progressive glomerulonephritis and indicates need for urgent renal biopsy and immunosuppression.

Pheochromocytoma is the classic endocrine cause, with sudden catecholamine release causing extreme hypertension (often >200/120 mmHg) with distinctive symptoms: severe headache, profuse diaphoresis, palpitations, and pallor. Attacks typically last 15-60 minutes. The ABCDE mnemonic for pheochromocytoma includes: Attacks (episodic hypertension), Blood pressure lability, Catecholamine effects (diaphoresis, palpitations, headache), Diabetes/Dyslipidemia, and Episodes of sweating. Thyroid storm with severe thyroiditis or excessive levothyroxine causes hypertensive emergency through increased sympathetic sensitivity. Cocaine and amphetamine intoxication causes acute catecholamine excess through increased sympathetic activity and monoamine oxidase inhibition.

Preeclampsia/eclampsia is the most common cause of hypertensive emergency in pregnant women. Seizures in eclampsia indicate severe cerebral involvement. Gestational hypertension that acutely worsens also presents this way. The pathophysiology involves placental release of soluble fms-like tyrosine kinase-1 (sFlt-1), which antagonizes vascular endothelial growth factor (VEGF), causing endothelial dysfunction and severe hypertension.

Acute ischemic stroke or hemorrhagic stroke trigger hypertensive emergency through sympathetic activation and increased intracranial pressure. This creates a diagnostic dilemma: does the hypertension cause the stroke, or is the hypertension a consequence of the stroke? Generally, in acute stroke, modest BP elevation (up to 180/110 mmHg) should be tolerated acutely without treatment, as aggressive BP lowering can worsen ischemic stroke. Only if BP exceeds thresholds for specific interventions (e.g., >185/110 mmHg for thrombolysis) should treatment begin.

Aortic dissection presents with sudden-onset tearing/ripping back pain and hypertensive emergency; immediate aggressive BP control (goal MAP 60 mmHg, HR <60 bpm) is essential to reduce aortic wall stress and prevent progression. Acute coronary syndrome with hypertensive emergency indicates increased myocardial oxygen demand and potential ischemia. Acute MI can trigger hypertensive emergency through catecholamine release and sympathetic activation.

Sympathomimetic drugs (cocaine, amphetamines, phenylephrine, pseudoephedrine) cause acute hypertensive emergency through direct alpha-adrenergic stimulation. MAOI interactions (tyramine-containing foods with MAOI antidepressants) cause hypertensive crisis. Oral contraceptives containing high-dose estrogen, especially in women with underlying hypertension or renal disease, increase risk. NSAIDs impair renal sodium handling and inhibit prostaglandin-mediated vasodilation, worsening hypertension. Decongestants and stimulant medications (methylphenidate, amphetamine-based ADHD medications) can precipitate crisis, particularly in non-adherent hypertensive patients.

Granulomatosis with polyangiitis (GPA, formerly Wegener's), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA) present with hypertensive emergency, glomerulonephritis, and systemic vasculitis. Systemic lupus erythematosus (SLE) causes hypertensive emergency through lupus nephritis and secondary RAAS activation. Presence of active urinary sediment and elevated inflammatory markers (ESR, CRP) helps distinguish these from primary hypertension.

Alcohol withdrawal causes sympathetic hyperactivity and hypertensive emergency. Acute intermittent porphyria (rare) presents with severe hypertension, abdominal pain, and neuropsychiatric symptoms. Cushing's syndrome and primary aldosteronism typically cause gradual hypertension but can occasionally present acutely if precipitant occurs.

Hypertensive encephalopathy causes progressive headache (often occipital), confusion, altered mental status, visual disturbances (scotomas, blurred vision from retinal hemorrhages), and ultimately seizures or coma if untreated. The headache is typically severe, throbbing, and refractory to standard analgesics—a clue to search for severely elevated BP. Posterior reversible encephalopathy syndrome (PRES), visible on MRI as white matter edema predominantly in the parietal and occipital lobes, represents the radiographic manifestation of hypertensive encephalopathy. Patients may describe photophobia and neck stiffness (mimicking meningitis), but lumbar puncture shows normal or mildly elevated protein without pleocytosis, distinguishing it from meningitis.

Chest pain or pressure, dyspnea, diaphoresis, and nausea indicate acute coronary syndrome triggered by increased myocardial oxygen demand or coronary vasospasm. EKG may show ischemic changes (ST-segment depression, T-wave inversions) without diagnostic ST elevation, indicating non-ST elevation MI (NSTEMI). Troponin elevation confirms myocardial necrosis. In cocaine-induced hypertensive emergency, chest pain with ischemic EKG changes and negative troponins initially is classic (troponin may rise with continued cocaine use or hours later).

Dyspnea at rest or with minimal exertion, orthopnea (awakening gasping for breath), paroxysmal nocturnal dyspnea, and pink frothy sputum indicate acute flash pulmonary edema from acute LV failure. This is particularly common in patients with chronic hypertension and LV hypertrophy who present with acute BP elevation. Physical exam reveals bilateral crackles, elevated JVP, S3 gallop, and peripheral edema if right heart failure supervenes.

Oliguria or anuria (urine output <400 mL/day) with rising serum creatinine and BUN indicates acute tubular necrosis from severe renal hypoperfusion and fibrinoid necrosis. Urinalysis shows dysmorphic RBCs, RBC casts, and proteinuria indicating glomerular injury; this is distinguished from prerenal azotemia (which shows muddy brown casts and epithelial cells). The fractional excretion of sodium (FENa) is typically >2-3%, indicating intrinsic renal disease rather than prerenal etiology. Progressive oliguria despite aggressive BP lowering is an ominous sign requiring consideration of TTP/HUS or severe vasculitis.

Schistocytes (fragmented RBCs, helmet cells) on peripheral blood smear, anemia with elevated reticulocyte count, elevated LDH, low haptoglobin, and elevated indirect bilirubin indicate mechanical hemolysis from fibrin strands in microvasculature. When accompanied by thrombocytopenia and AKI, this constitutes the triad of TTP/HUS or hypertensive emergency-associated microangiopathy. Notably, coagulation studies (PT, aPTT, fibrinogen) are typically normal or only mildly abnormal—this distinguishes microangiopathic hemolysis from DIC.

Fundoscopic exam reveals the hallmark findings: flame hemorrhages (superficial retinal bleeding in nerve fiber layer), dot and blot hemorrhages (deeper hemorrhages in inner nuclear layer), cotton-wool spots (nerve fiber layer infarcts appearing as white fluffy spots), hard exudates (lipid deposits from vascular leakage, often in a "macular star" pattern), and papilledema (optic disc swelling from increased intracranial pressure). Severe hypertension also causes Roth spots (round retinal hemorrhages with white centers, from platelet thrombi or septic emboli in bacterial endocarditis, but also seen in severe hypertension). The presence of papilledema with hypertension indicates hypertensive encephalopathy rather than simple hypertensive retinopathy and necessitates aggressive BP control.

Aortic dissection presents with sudden-onset tearing or ripping back pain, radiating to the chest, abdomen, or legs depending on extent. Differential perfusion between true and false lumens causes pulse deficits (unequal blood pressures between arms), new aortic regurgitation murmur (if dissection involves ascending aorta), and neurological deficits from stroke (if carotid arteries involved). Acute coronary dissection (spontaneous coronary artery dissection, SCAD) presents with acute MI and is increasingly recognized in young patients, particularly peripartum women

Step 1 — confirm the pressure: repeat the reading manually with a correctly sized cuff (an undersized cuff falsely elevates) in both arms; an inter-arm systolic difference >20 mmHg raises suspicion for aortic dissection. A single automated triage reading is never sufficient to commit a patient to IV therapy.

Step 2 — the test that actually makes the diagnosis is the end-organ survey, since emergency and urgency share the same blood pressure:

Named thresholds: the ACC/AHA 2017 hypertension guideline defines emergency as BP typically ≥180/120 mmHg with acute target-organ damage; ACOG defines preeclampsia with severe features at ≥160/110 mmHg on two occasions. Once stabilized, screen for secondary causes (plasma free metanephrines, aldosterone-to-renin ratio, renal artery imaging, TSH), especially in young or treatment-resistant patients.

Triage decision first: the presence or absence of acute end-organ damage, not the number, decides the route of therapy.

Hypertensive emergency — general principle (ACC/AHA 2017): ICU admission, continuous or intra-arterial monitoring, titratable IV agents. Reduce MAP by no more than 25% in the first hour, then to roughly 160/100–110 mmHg over the next 2–6 hours, then to normal over 24–48 hours. The rightward-shifted autoregulatory curve of chronic hypertension is why faster lowering causes watershed ischemia.

Contraindicated: ACE inhibitors and ARBs in pregnancy — captopril included, its short half-life makes it a titratable oral agent, not a pregnancy-safe one; nitroprusside in pregnancy; beta blocker monotherapy in cocaine or pheochromocytoma. In acute ischemic stroke, AHA/ASA supports permissive hypertension unless BP exceeds thrombolysis thresholds (185/110 mmHg) or is extremely elevated.